News UK Chancellor’s budget welcomed by biopharma sector Industry groups are happy with news on R&D tax credits, funding for MHRA, and investment zones.
News US imposes first rebates on drugs with price hikes Manufacturers will have to pay or face fines on drugs whose prices rose ahead of inflation.
News Changing Faces: Biopharma hires from February 2023 Read on for all the pharma personnel news we heard about this month.
News Novo Nordisk shadows Lilly with insulin price cut plan Danish drugmaker says it will reduce the price of its insulin products in the US by up to 75%.
News First major insurer covers Eisai’s Alzheimer’s drug Leqembi Department of Veterans Affairs will cover the drug for veterans with early-stage Alzheimer's.
News Rumour of Pfizer, Seagen deal is true, with $43bn price tag Pfizer says Seagen's current and future drugs could add $10 billion to its revenues from 2030.
News Senju launches first-in-class dry eye disease drug in Japan Senju has launched a new drug for dry eye disease (DED) in Japan, Avarept, the first drug in the TRPV1 antagonist class to reach the market.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
